Research / MAMA / Fundamental state Inspectable configuration
State dimensions Filing 0001493152-21-009285 General Corporate
Capex intensity 45th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.03% · OPTIONAL · VALID
Operating cash generation 64th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
9.07% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
17.00% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 0th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
2.93% · OPTIONAL · VALID
Gross margin 9th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.gross_margin
31.26% · CORE · VALID
Operating margin 91th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.operating_margin
8.53% · CORE · VALID
R&D intensity 18th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.27% · OPTIONAL · VALID
SBC intensity 9th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.13% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 35 states Self-history eligible
Jan 31, 2022 8/8 normalized Level 3 Apr 30, 2022 7/7 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 31, 2022 6/6 normalized Level 3 Jan 31, 2023 7/7 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Amended as filed Jul 31, 2023 8/8 normalized Level 3 Oct 31, 2023 8/8 normalized Level 3 Jan 31, 2024 8/8 normalized Level 3 Apr 30, 2024 8/8 normalized Level 3 Jul 31, 2024 8/8 normalized Level 3 Oct 31, 2024 8/8 normalized Level 3 Jan 31, 2025 8/8 normalized Level 3 Apr 30, 2025 8/8 normalized Level 3 Jul 31, 2025 8/8 normalized Level 3 Oct 31, 2025 8/8 normalized Level 3 Jan 31, 2026 9/9 normalized Level 3 Apr 30, 2026 8/8 normalized Level 3 Jul 31, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 1.16%
Current 1.03%
Delta -0.13% Cash Generation Decreased
Previous 10.63%
Current 9.07%
Delta -1.55% Growth Increased
Previous 6.82%
Current 17.00%
Delta 10.18% Inventory Pressure Decreased
Previous 15.76%
Current 2.93%
Delta -12.83% Margin Decreased
Previous 31.57%
Current 31.26%
Delta -0.32% Profitability Increased
Previous 7.95%
Current 8.53%
Delta 0.58% R And D Intensity Decreased
Previous 0.31%
Current 0.27%
Delta -0.04% Sbc Intensity Increased
Previous 0.01%
Current 0.13%
Delta 0.12% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.